AlphaRose Therapeutics Secured SBIR Fast Track Grant
The Austin-based biotech firm received federal funding to advance its drug candidate for a rare genetic condition.
Live Poll
Do you trust that AI-driven drug discovery will effectively improve treatment access for rare diseases?